[Federal Register Volume 75, Number 172 (Tuesday, September 7, 2010)]
[Notices]
[Page 54330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22175]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive Field of Use License of a U.S. 
Government-Owned Patent Application

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7 
(a)(1)(i), announcement is made of the intent to grant an exclusive, 
revocable license for the field of use in the research reagent market 
to the invention described in U.S. Patent Application No. 61/252,675 
entitled ``Enhanced Substrates for The Protease Activity of Serotype A 
Botulinum Neurotoxin,'' filed October 18, 2009, to List Biological 
Laboratories, with its principal place of business at 540 Division 
Street, Campbell, California 95008-6906.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research and Technology Applications (ORTA), (301) 619-6664. 
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-
7808, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-22175 Filed 9-3-10; 8:45 am]
BILLING CODE 3710-08-P